Selected research
Industry Research
Atosiban Industry Research Report 2026
Market perspective
The global Atosiban market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Atosiban is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Atosiban is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Atosiban is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Atosiban include Sun Pharma, Shanghai Soho-Yiming Pharmaceuticals, Ferring Pharmaceuticals, Hangzhou Longshine Bio-Tech, Neore Pharmaceutical, EVER Pharma and Cayman Chemical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Atosiban market in terms of revenue (US$ million) and, where applicable, sales volume (kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Atosiban Market by Company
Sun Pharma
Shanghai Soho-Yiming Pharmaceuticals
Ferring Pharmaceuticals
Hangzhou Longshine Bio-Tech
Neore Pharmaceutical
EVER Pharma
Cayman Chemical
Atosiban Segment by Type
Injection
Concentrate
Atosiban Segment by Application
Hospital Pharmacies
Online Pharmacies
Atosiban Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Atosiban market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Atosiban and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Atosiban.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Atosiban manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Atosiban by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Atosiban in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Injection
- Concentrate
Applications
- Hospital Pharmacies
- Online Pharmacies
Companies covered
- Sun Pharma
- Shanghai Soho-Yiming Pharmaceuticals
- Ferring Pharmaceuticals
- Hangzhou Longshine Bio-Tech
- Neore Pharmaceutical
- EVER Pharma
- Cayman Chemical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Atosiban Market Size (2021-2032)
- 2.2.2 Global Atosiban Sales (2021-2032)
- 2.2.3 Global Atosiban Market Average Price (2021-2032)
- 2.3 Atosiban by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Injection
- 2.3.3 Concentrate
- 2.4 Atosiban by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital Pharmacies
- 2.4.3 Online Pharmacies
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Atosiban Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Atosiban Sales (kg) of Manufacturers (2021-2026)
- 3.3 Global Atosiban Revenue of Manufacturers (2021-2026)
- 3.4 Global Atosiban Average Price by Manufacturers (2021-2026)
- 3.5 Global Atosiban Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Atosiban, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Atosiban, Product Type & Application
- 3.8 Global Manufacturers of Atosiban, Established Date
- 3.9 Global Atosiban Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sun Pharma
- 4.1.1 Sun Pharma Company Information
- 4.1.2 Sun Pharma Business Overview
- 4.1.3 Sun Pharma Atosiban Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sun Pharma Atosiban Product Portfolio
- 4.1.5 Sun Pharma Recent Developments
- 4.2 Shanghai Soho-Yiming Pharmaceuticals
- 4.2.1 Shanghai Soho-Yiming Pharmaceuticals Company Information
- 4.2.2 Shanghai Soho-Yiming Pharmaceuticals Business Overview
- 4.2.3 Shanghai Soho-Yiming Pharmaceuticals Atosiban Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Shanghai Soho-Yiming Pharmaceuticals Atosiban Product Portfolio
- 4.2.5 Shanghai Soho-Yiming Pharmaceuticals Recent Developments
- 4.3 Ferring Pharmaceuticals
- 4.3.1 Ferring Pharmaceuticals Company Information
- 4.3.2 Ferring Pharmaceuticals Business Overview
- 4.3.3 Ferring Pharmaceuticals Atosiban Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Ferring Pharmaceuticals Atosiban Product Portfolio
- 4.3.5 Ferring Pharmaceuticals Recent Developments
- 4.4 Hangzhou Longshine Bio-Tech
- 4.4.1 Hangzhou Longshine Bio-Tech Company Information
- 4.4.2 Hangzhou Longshine Bio-Tech Business Overview
- 4.4.3 Hangzhou Longshine Bio-Tech Atosiban Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Hangzhou Longshine Bio-Tech Atosiban Product Portfolio
- 4.4.5 Hangzhou Longshine Bio-Tech Recent Developments
- 4.5 Neore Pharmaceutical
- 4.5.1 Neore Pharmaceutical Company Information
- 4.5.2 Neore Pharmaceutical Business Overview
- 4.5.3 Neore Pharmaceutical Atosiban Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Neore Pharmaceutical Atosiban Product Portfolio
- 4.5.5 Neore Pharmaceutical Recent Developments
- 4.6 EVER Pharma
- 4.6.1 EVER Pharma Company Information
- 4.6.2 EVER Pharma Business Overview
- 4.6.3 EVER Pharma Atosiban Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 EVER Pharma Atosiban Product Portfolio
- 4.6.5 EVER Pharma Recent Developments
- 4.7 Cayman Chemical
- 4.7.1 Cayman Chemical Company Information
- 4.7.2 Cayman Chemical Business Overview
- 4.7.3 Cayman Chemical Atosiban Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Cayman Chemical Atosiban Product Portfolio
- 4.7.5 Cayman Chemical Recent Developments
5 Global Atosiban Market Scenario by Region
- 5.1 Global Atosiban Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Atosiban Sales by Region: 2021-2032
- 5.2.1 Global Atosiban Sales by Region: 2021-2026
- 5.2.2 Global Atosiban Sales by Region: 2027-2032
- 5.3 Global Atosiban Revenue by Region: 2021-2032
- 5.3.1 Global Atosiban Revenue by Region: 2021-2026
- 5.3.2 Global Atosiban Revenue by Region: 2027-2032
- 5.4 North America Atosiban Market Facts & Figures by Country
- 5.4.1 North America Atosiban Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Atosiban Sales by Country (2021-2032)
- 5.4.3 North America Atosiban Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Atosiban Market Facts & Figures by Country
- 5.5.1 Europe Atosiban Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Atosiban Sales by Country (2021-2032)
- 5.5.3 Europe Atosiban Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Atosiban Market Facts & Figures by Country
- 5.6.1 Asia Pacific Atosiban Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Atosiban Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Atosiban Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Atosiban Market Facts & Figures by Country
- 5.7.1 South America Atosiban Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Atosiban Sales by Country (2021-2032)
- 5.7.3 South America Atosiban Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Atosiban Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Atosiban Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Atosiban Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Atosiban Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Atosiban Sales by Type (2021-2032)
- 6.1.1 Global Atosiban Sales by Type (2021-2032) & (kg)
- 6.1.2 Global Atosiban Sales Market Share by Type (2021-2032)
- 6.2 Global Atosiban Revenue by Type (2021-2032)
- 6.2.1 Global Atosiban Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Atosiban Revenue Market Share by Type (2021-2032)
- 6.3 Global Atosiban Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Atosiban Sales by Application (2021-2032)
- 7.1.1 Global Atosiban Sales by Application (2021-2032) & (kg)
- 7.1.2 Global Atosiban Sales Market Share by Application (2021-2032)
- 7.2 Global Atosiban Revenue by Application (2021-2032)
- 7.2.1 Global Atosiban Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Atosiban Revenue Market Share by Application (2021-2032)
- 7.3 Global Atosiban Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Atosiban Value Chain Analysis
- 8.1.1 Atosiban Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Atosiban Production Mode & Process
- 8.2 Atosiban Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Atosiban Distributors
- 8.2.3 Atosiban Customers
9 Global Atosiban Analyzing Market Dynamics
- 9.1 Atosiban Industry Trends
- 9.2 Atosiban Industry Drivers
- 9.3 Atosiban Industry Opportunities and Challenges
- 9.4 Atosiban Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst